P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON-HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS-3 TRIAL

• P. L. Zinzani,
• M. Özcan,
• K. Sapunarova,
• W. Jurczak,
• A. Hamed,
• K. Bouabdallah,
• G. Saydam,
• K. Geissler,
• Á. Szomor,
• M. Lazaroiu,
• A. Salar,
• A. Tempescul,
• M. Nalcaci,
• L. Gercheva,
• M. Egyed,
• P. Panayiotidis,
• L. Mongay Soler,
• A. Cao,
• C. Phelps,
• B. H Childs,
• M. J Matasar

Affiliations

P. L. Zinzani

1 IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seragnoli”

M. Özcan

3 Ankara University School of Medicine, Ankara, Turkey

K. Sapunarova

4 Medical University, Plovdiv, Bulgaria

W. Jurczak

5 Maria Skłodowska Curie National Research Institute of Oncology, Krakow, Poland

A. Hamed

6 Petz Aladár Megyei Oktató Kórház, Gyor, Hungary

K. Bouabdallah

7 Hematology and Cellular Therapy Department, University Hospital of Bordeaux, Bordeaux, France

G. Saydam

8 Ege Üniversitesi Tip Fakültesi, Izmir, Turkey

K. Geissler

9 Sigmund Freud University, Vienna, Austria

Á. Szomor

10 Pécsi Tudományegyetem Klinikai Központ, Pécs, Hungary

M. Lazaroiu

11 S.C. Policlinica de Diagnostic Rapid S.A., Brasov, Romania

A. Salar

12 Hospital del Mar, Barcelona, Spain

A. Tempescul

13 Hôpital Morvan - Brest, Brest, France

M. Nalcaci

14 Istanbul Universitesi İstanbul Tip Fakultesi, Istanbul, Turkey

L. Gercheva

15 MHAT Sveta Marina EAD, Varna, Bulgaria

M. Egyed

16 Somogy Megyei Kaposi Mor Oktato Korhaz, Kaposvar, Hungary

P. Panayiotidis

17 First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

L. Mongay Soler

18 Bayer HealthCare Pharmaceuticals, Inc., Whippany, NJ

A. Cao

18 Bayer HealthCare Pharmaceuticals, Inc., Whippany, NJ

C. Phelps

18 Bayer HealthCare Pharmaceuticals, Inc., Whippany, NJ

B. H Childs

18 Bayer HealthCare Pharmaceuticals, Inc., Whippany, NJ

M. J Matasar

19 Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America